CRP and metabolic syndrome: Several studies showed that patients with MetS were more likely than those without to have elevated levels of a marker of inflammation such as C-reactive protein (CRP) as well as proinflammatory cytokines such as TNF-α, IL-8, IL-6, and IL-1β [83, 84].